We break down the biggest gainers and droppers in the Cheddar 50 index this year, plus one Japanese stock that's made a big splash in the U.S. in 2017. On the plus side, shares of Square have risen about 160 percent this year as the digital payment company has expanded into new markets. And video game maker Take-Two Interactive has also more than doubled in 2017, as investors and fans both await the release of Red Dead Redemption 2 this spring. But they weren't all winners. Pandora shares were down more than 60 percent as the music streaming service struggled to grow paying subscribers. And Blue Apron stock has dropped as much as 70 percent since its IPO in late June, losing its CEO and cutting jobs. Plus, what about Japan's SoftBank? The tech holding company launched its $100 billion Vision Fund, which has made investments in Nvidia, WeWork and Flipkart. And we're still waiting for what could be a $10 billion investment in Uber.

Share:
More In Business
Hard pass, Cold brew, Dad bod: Merriam-Webster adds 5,000 new words
Merriam-Webster has fully revised its popular “Collegiate” dictionary with over 5,000 new words. They include “petrichor,” “dumbphone” and “ghost kitchen.” Also “cold brew,” “rizz,” “dad bod,” “hard pass,” “cancel culture” and more.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More